PHAT
PHAT
NASDAQ · Pharmaceuticals

Phathom Pharmaceuticals Inc

$10.88
-0.12 (-1.09%)
As of Jun 21, 10:11 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +366.4% upside
Low Target $34.41
Average Target $50.74
High Target $70.04
Current Price $10.88
Current
$10.88
Target
$50.74
$34.41 $50.74 avg $70.04
Scenario Analysis
Bear Case
$34.41
216.3%
Low target
Base Case
$50.74
+366.4%
Avg target
Bull Case
$70.04
+543.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$18.31
-40.6% from high
52-Week Low
$7.61
+43.0% from low
Target vs 52W High
$50.74
+177.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%